Blood pressure monitoring
-
Blood pressure monitoring · Feb 2006
Reliability of a noninvasive device to measure systemic hemodynamics in hemodialysis patients.
To evaluate the reliability of a noninvasive hemodynamic monitor in hemodialysis patients. ⋯ We conclude that the Dynapulse 500 Guardian has adequate reliability indices in hemodialysis patients.
-
Blood pressure monitoring · Feb 2006
Validation of the Omron 705IT (HEM-759-E) oscillometric blood pressure monitoring device according to the British Hypertension Society protocol.
The Omron 705IT (HEM-759-E, Omron Corporation, Kyoto, Japan) is an automated oscillometric upper arm blood pressure monitor for the professional and home use markets. The aim of this study was to validate the accuracy of this device according to the British Hypertension Society and the Association for the Advancement of Medical Instrumentation SP10 validation criteria. ⋯ The Omron 705IT (HEM-759-E) achieved an 'A/A' performance classification under the British Hypertension Society criteria and passes the Association for the Advancement of Medical Instrumentation requirements for the study population. It can be recommended for professional and home-use in an adult population.
-
Blood pressure monitoring · Dec 2005
Validation of the TM-2564G device for in-hospital blood pressure measurement.
To perform clinical validation of the TM-2564G device for in-hospital blood pressure measurement according to the British Hypertension Society protocol. ⋯ The TM-2564G device achieved A/A British Hypertension Society grade and can be recommended for in-hospital measurement of blood pressure.
-
Blood pressure monitoring · Apr 2005
Randomized Controlled Trial Multicenter Study Comparative Study Clinical Trial24-hour ambulatory blood-pressure effects of valsartan and hydrochlorothiazide combinations compared with amlodipine in hypertensive patients at increased cardiovascular risk: a VAST sub-study.
There is a lack of data on the effects of angiotensin-receptor blocker and diuretic combinations on ambulatory blood pressure (ABP) in hypertensive patients with additional cardiovascular risk factors. ⋯ The fixed-dose combination of valsartan 160 mg+HCTZ 25 mg od is an attractive therapeutic option measured on the effects on 24-h ABPM, night-time and daytime BP reduction and control rates in hypertensive patients at additional cardiovascular risk.
-
Blood pressure monitoring · Apr 2005
Clinical Trial Controlled Clinical TrialInaccuracy of wrist-cuff oscillometric blood pressure devices: an arm position artefact?
Despite the increasing popularity of wrist-cuff blood pressure (BP) devices, their accuracy has not been established and international guidelines do not support their use. Because arm position influences BP measurement, it is possible that conflicting reports on wrist-cuff device accuracy reflects diverse arm positions. ⋯ This study supports the use of wrist-cuff monitors for self/home use and underlines the need for a more precise definition for arm position when using all BP devices -- mercury and oscillometric.